Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery

Breast Cancer Clinical Trial

Official title:

Comparison of the Effects of Serratus Plane Block and Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04218149
• Other study ID #: KS01
• Status: Completed
• Phase: Phase 4
• Start date: May 1, 2019
• Est. completion date: October 1, 2019

Study information

• Verified date: April 2019
• Source: Sisli Hamidiye Etfal Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Interfacial plan blocks are becoming more widely used for postoperative analgesia because of their easier applicability and less risk of complications. In this study, we aimed to compare the effects of serratus plane block (SPB) and erector spinae plane block (ESPB) on postoperative analgesia in patients undergoing unilateral breast surgery

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: October 1, 2019
• Est. primary completion date: September 29, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• ASA I-II

• Age: 18 - 65 years

• unilateral breast surgery

Exclusion Criteria:

• Does not approve the study

• Pregnant

• Emergency

• ASA III-IV

• History of local anesthetic allergy

• Infection in the block area

• Coagulation disorder

• Morbid obesity (body mass index> 40 kg / m²)

• Severe organ failure

• Previous neurological deficit

• Psychiatric disease

• History of chronic pain

Related Conditions & MeSH terms

• Breast Cancer
• Pain, Postoperative
• Postoperative Pain

Intervention

Drug:
• Bupivacaine Injection
Block with bupivacaine

Locations

Country	Name	City	State
Turkey	SBÜ Sisli Hamidiye Etfal Egitim ve Arastirma Hastanesi	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Sisli Hamidiye Etfal Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative pain score	Visual analog scale (0-10), <4 is adequate analgesia	Postoperative 24 hours
Primary	Postoperative tramadol consumption	Postoperative opiodi consumption with patient controlled analgesia	Postoperative 24 hours
Primary	Rescue analgesic	If VAS score is 4 or more, paracetamol 1 gr is administered	Postoperative 24 hours
Secondary	Analgesia time	Time from block performing to first analgesia requirement	Procedure